Suicide Risk From Weight-Loss Drugs Prompts More Questions
The European Union’s drugs regulator has asked pharma companies including Novo Nordisk A/S and Eli Lilly & Co.
2023-12-02 06:19
Novo to Build $6 Billion Plant as Obesity Drug Demand Surges
Novo Nordisk A/S will invest more than 42 billion kroner ($6 billion) to expand its manufacturing facilities as
2023-11-10 21:22
Astra Enters Obesity Drug Race, Trumpets Price Potential
AstraZeneca Plc clinched a deal to develop a drug from the pharma industry’s hottest class of medicines and
2023-11-09 21:47
European Stocks On Track for Best Run Since July on Fed Optimism
European shares advanced for a fourth day, set for their longest winning streak since July, fueled by hopes
2023-11-02 18:48
When Japan Ends Negative Rate Policy, Treasuries Will Suffer
Japan’s era of negative interest rates will end in coming months, and the implications for world markets will
2023-10-23 08:56
Novo Weight Drugs Probed Over Reports of Suicidal Thoughts
Novo Nordisk A/S’s weight-loss medications are under investigation by the European Union’s drugs regulator after a small number
2023-07-10 22:27
Last Taboo for Hit Obesity Drug Is Asking When to Stop
Two years and more than a million prescriptions after Wegovy first went on sale, there’s one taboo question
2023-06-30 12:15
Eli Lilly’s Experimental Weight-Loss Shot Gives Company’s Strongest Results Yet
An experimental weight-loss shot from Eli Lilly & Co. yielded the strongest results of any of its treatments
2023-06-27 05:28
Novo Nordisk Plans $2.3 Billion Manufacturing Expansion in Denmark
Novo Nordisk A/S is spending 15.9 billion Danish kroner ($2.29 billion) to expand production facilities in Denmark as
2023-06-12 14:16